Accès ouvert
2025
article
OpenAlex
Marco Öchsner, Matthias Brendel, Nicolai Franzmeier, Lena‐Katharina Trappmann et autres
Abstract Background Recent evidence suggests that microglial activation mirrors tau accumulation along highly connected brain regions, but their relation remains unclear. We examined (a) longitudinal changes in microglial activation in Alzheimer's disease spectrum (ADS) compared to healthy controls (HC) (b) whether these …
de, ch, gb
(code pays fourni par la source)
Accès ouvert
2025
conference-paper
OpenAlex
Marco Öchsner, Matthias Brendel, Nicolai Franzmeier, Lena-Katharina Trappmann et autres
Background Recent evidence suggests that microglial activation mirrors tau accumulation along highly connected brain regions, but their relation remains unclear. We examined (a) longitudinal changes in microglial activation in Alzheimer's disease spectrum (ADS) compared to healthy controls (HC) (b) whether these changes …
Accès ouvert
2025
article
OpenAlex
Carolin Meyer, Theresa Niedermeier, Paul Feyen, Felix L. Struebing et autres
Abstract Alzheimer’s disease (AD) often begins with non-cognitive symptoms such as olfactory deficits, which can predict later cognitive decline, though the mechanisms remain unclear. Pathologically, the brainstem locus coeruleus (LC), the main source of the neurotransmitter noradrenalin (NA) modulating olfactory information processing …
de, au, gb
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Philine Schirge, Robert Perneczky, Toshiaki Taoka, Adriana L. Ruiz‐Rizzo et autres
BACKGROUND: Alzheimer's disease (AD) is the leading cause of dementia, characterized by the accumulation of amyloid-beta (Aβ) and neurofibrillary tangles. Recent studies emphasize the role of vascular factors, including the glymphatic system, in AD pathogenesis, particularly in Aβ clearance. The diffusion tensor …
de, gb, jp
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Boris‐Stephan Rauchmann, Selim Guersel, Carolin Kurz, Simon Lindner et autres
Abstract Background Alzheimer's Disease (AD) is often accompanied by neuroinflammation, which manifests prior to significant cognitive decline. Reactive astrocytosis is a hallmark of such inflammation, potentially serving as an early biomarker for AD pathology. Our study employs [18F]fluorodeprenyl‐D2 ([18F]F‐DED) positron emission tomography …
de
(code pays fourni par la source)
Accès ouvert
2024
preprint
OpenAlex
Carolin Meyer, Theresa Niedermeier, Paul Feyen, Felix Strübing et autres
de, au
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Jonathan S. Vogelgsang, Niels Hansen, Melina Stark, Michael Wagner et autres
INTRODUCTION: Blood-based biomarkers are a cost-effective and minimally invasive method for diagnosing the early and preclinical stages of amyloid positivity (AP). Our study aims to investigate our novel immunoprecipitation-immunoassay (IP-IA) as a test for predicting cognitive decline. METHODS: We measured levels of …
us, de, gb, lu, pt
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Gloria Biechele, Boris‐Stephan Rauchmann, Daniel Janowitz, Katharina Büerger et autres
Abstract Background and objectives 18-kDa translocator protein position-emission-tomography (TSPO-PET) imaging emerged for in vivo assessment of neuroinflammation in Alzheimer’s disease (AD) research. Sex and obesity effects on TSPO-PET binding have been reported for cognitively normal humans (CN), but such effects have not …
de, gb, se, ch
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Carolin Kurz, Laura De Carli, Selim Guersel, Isabelle Schrurs et autres
Abstract Background Cerebrospinal fluid (CSF) and positron emission tomography (PET) biomarkers of Alzheimer’s disease (AD), ß‐amyloid (Aß) and tau, can identify early disease stages with high accuracy. However, this approach is not suitable for routine clinical care because of the high costs …
de, ch, gb
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Boris‐Stephan Rauchmann, Hannah Toth, Selim Guersel, Philine Schirge et autres
Abstract Background Alzheimer’s disease (AD) is characterized by the accumulation of amyloid beta (Aβ) plaques in the brain. Blood‐brain barrier (BBB) dysfunction has been associated with AD. Aβ‐plaques have been found to disrupt the BBB, leading to increased permeability and invasion of …
de, gb
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Boris‐Stephan Rauchmann, Hannah Toth, Selim Guersel, Philine Schirge et autres
Abstract Background Alzheimer’s disease (AD) is characterized by the accumulation of amyloid beta (Aß) plaques in the brain. Blood‐brain barrier (BBB) dysfunction has been associated with AD. Aß‐plaques have been found to disrupt the BBB, leading to increased permeability and invasion of …
gb, de
(code pays fourni par la source)
Accès ouvert
2023
preprint
OpenAlex
Gloria Biechele, Boris‐Stephan Rauchmann, Daniel Janowitz, Katharina Büerger et autres
Abstract Background and Objectives: 18-kDa translocator protein position-emission-tomography (TSPO-PET) imaging emerged for in vivo assessment of neuroinflammation in Alzheimer’s disease (AD) research. Sex and obesity effects on TSPO-PET binding have been reported for cognitively normal humans (CN), but such effects have not …
de, ch
(code pays fourni par la source)